ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 109 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $676,255 | -50.2% | 127,277 | -10.7% | 0.00% | – |
| Q2 2023 | $1,356,809 | -71.8% | 142,599 | -67.5% | 0.00% | -100.0% |
| Q1 2023 | $4,819,085 | +87807.4% | 438,115 | +18.3% | 0.00% | 0.0% |
| Q4 2022 | $5,482 | -99.9% | 370,490 | +18.0% | 0.00% | 0.0% |
| Q3 2022 | $5,999,000 | -10.0% | 313,943 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $6,664,000 | +52.2% | 312,608 | +37.5% | 0.00% | +100.0% |
| Q1 2022 | $4,378,000 | +70.4% | 227,383 | +83.5% | 0.00% | 0.0% |
| Q4 2021 | $2,569,000 | +35.6% | 123,906 | +56.1% | 0.00% | 0.0% |
| Q3 2021 | $1,894,000 | +48.3% | 79,395 | +69.7% | 0.00% | – |
| Q2 2021 | $1,277,000 | – | 46,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |